• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝组织在终末期胆汁淤积性肝病中的 DNA 甲基化谱。

DNA methylation profile of liver tissue in end-stage cholestatic liver disease.

机构信息

Division of Gastroenterology, The Ottawa Hospital, Ottawa, ON, K1H 8L6, Canada.

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.

出版信息

Epigenomics. 2022 Apr;14(8):481-497. doi: 10.2217/epi-2021-0343. Epub 2022 Apr 27.

DOI:10.2217/epi-2021-0343
PMID:35473391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9096606/
Abstract

In this methylome-wide association study of cholestatic liver diseases (primary sclerosing cholangitis and primary biliary cholangitis), the authors aimed to elucidate changes in methylome and pathway enrichment to identify candidate genes Reduced representation bisulfite sequencing was performed on liver tissue from 58 patients with primary sclerosing cholangitis (n = 13), primary biliary cholangitis (n = 20), alcoholic liver disease (n = 21) and live liver donors (n = 4). Pathway enrichment and network analysis were used to explore key genes/pathways. Both cholestatic liver diseases were characterized by global hypomethylation, with pathway enrichment demonstrating distinct genes and pathways associated with the methylome. This novel study demonstrated that differential methylation in cholestatic liver disease was associated with unique pathways, suggesting it may drive disease pathogenesis.

摘要

在这项关于胆汁淤积性肝病(原发性硬化性胆管炎和原发性胆汁性胆管炎)的全基因组甲基化关联研究中,作者旨在阐明甲基化组的变化和途径富集,以确定候选基因。对 58 名原发性硬化性胆管炎(n=13)、原发性胆汁性胆管炎(n=20)、酒精性肝病(n=21)和活体肝供体(n=4)患者的肝组织进行了简化代表性双硫代测序。利用途径富集和网络分析来探索关键基因/途径。这两种胆汁淤积性肝病均表现为全基因组低甲基化,途径富集显示与甲基化组相关的独特基因和途径。这项新的研究表明,胆汁淤积性肝病中的差异甲基化与独特的途径相关,提示其可能驱动疾病发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/80c95bac4643/epi-14-481-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/efdfb09b07c6/epi-14-481-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/7c52057e4a35/epi-14-481-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/981f58c9c129/epi-14-481-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/771c73bf9a49/epi-14-481-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/e6a9ea115d0c/epi-14-481-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/80c95bac4643/epi-14-481-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/efdfb09b07c6/epi-14-481-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/7c52057e4a35/epi-14-481-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/981f58c9c129/epi-14-481-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/771c73bf9a49/epi-14-481-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/e6a9ea115d0c/epi-14-481-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0f/9096606/80c95bac4643/epi-14-481-g6.jpg

相似文献

1
DNA methylation profile of liver tissue in end-stage cholestatic liver disease.肝组织在终末期胆汁淤积性肝病中的 DNA 甲基化谱。
Epigenomics. 2022 Apr;14(8):481-497. doi: 10.2217/epi-2021-0343. Epub 2022 Apr 27.
2
Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.全基因组分辨率外周血甲基组谱分析揭示胆汁淤积性肝病特征。
Epigenomics. 2020 Aug;12(16):1363-1375. doi: 10.2217/epi-2020-0048. Epub 2020 Sep 11.
3
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease.原发性硬化性胆管炎和原发性胆汁性胆管炎中的表观遗传学疾病标志物-胆汁淤积性肝病的甲基组学
Hepatol Commun. 2024 Jul 18;8(8). doi: 10.1097/HC9.0000000000000496. eCollection 2024 Aug 1.
4
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.原发性胆汁性肝硬化和原发性硬化性胆管炎患者血清中 17 种胆汁酸的代谢组学分析:一项初步研究。
Dig Liver Dis. 2012 Apr;44(4):303-10. doi: 10.1016/j.dld.2011.10.025. Epub 2011 Dec 9.
5
Primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎。
Clin Liver Dis. 1999 Aug;3(3):529-70. doi: 10.1016/s1089-3261(05)70084-2.
6
Plasma antioxidant levels in chronic cholestatic liver diseases.慢性胆汁淤积性肝病中的血浆抗氧化剂水平。
Aliment Pharmacol Ther. 2000 Mar;14(3):353-8. doi: 10.1046/j.1365-2036.2000.00729.x.
7
Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.原发性胆汁性胆管炎和原发性硬化性胆管炎中的表观遗传学。
Semin Liver Dis. 2017 May;37(2):159-174. doi: 10.1055/s-0037-1603324. Epub 2017 May 31.
8
Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的识别
Am Fam Physician. 1996 Jan;53(1):195-200.
9
Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.乳糜泻患者的自身免疫性胆汁淤积性肝病:基于人群的两者关联研究
Aliment Pharmacol Ther. 2005 Feb 15;21(4):401-5. doi: 10.1111/j.1365-2036.2005.02328.x.
10
HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.原发性硬化性胆管炎和原发性胆汁性肝硬化中的HLA DPB多态性
Hepatology. 1995 Apr;21(4):959-62.

引用本文的文献

1
Central role for cholangiocyte pathobiology in cholestatic liver diseases.胆管细胞病理生物学在胆汁淤积性肝病中的核心作用。
Hepatology. 2024 Sep 9. doi: 10.1097/HEP.0000000000001093.
2
The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols.肝纤维化的可能发病机制:天然多酚的治疗潜力。
Pharmacol Rep. 2024 Oct;76(5):944-961. doi: 10.1007/s43440-024-00638-w. Epub 2024 Aug 20.
3
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease.

本文引用的文献

1
A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells.原发性硬化性胆管炎的胆汁免疫景观图谱揭示了中性粒细胞和组织驻留T细胞的主导网络。
Sci Transl Med. 2021 Jun 23;13(599). doi: 10.1126/scitranslmed.abb3107.
2
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者外周血中的甲基化特征与显著的年龄加速和疾病进展相关。
JHEP Rep. 2019 Dec 5;2(1):100060. doi: 10.1016/j.jhepr.2019.11.004. eCollection 2020 Feb.
3
Promoter hypermethylation of the gene in PBC.
原发性硬化性胆管炎和原发性胆汁性胆管炎中的表观遗传学疾病标志物-胆汁淤积性肝病的甲基组学
Hepatol Commun. 2024 Jul 18;8(8). doi: 10.1097/HC9.0000000000000496. eCollection 2024 Aug 1.
原发性胆汁性胆管炎中该基因的启动子高甲基化
JHEP Rep. 2019 Jun 7;1(3):145-153. doi: 10.1016/j.jhepr.2019.05.006. eCollection 2019 Sep.
4
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update).g:Profiler:一个用于功能富集分析和基因列表转换的网络服务器(2019 更新)。
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198. doi: 10.1093/nar/gkz369.
5
The emerging role of epigenetics in human autoimmune disorders.表观遗传学在人类自身免疫性疾病中的新兴作用。
Clin Epigenetics. 2019 Feb 26;11(1):34. doi: 10.1186/s13148-019-0632-2.
6
New guidelines for DNA methylome studies regarding 5-hydroxymethylcytosine for understanding transcriptional regulation.关于理解转录调控的 5-羟甲基胞嘧啶的 DNA 甲基化组学研究的新指南。
Genome Res. 2019 Apr;29(4):543-553. doi: 10.1101/gr.240036.118. Epub 2019 Feb 19.
7
Multigenerational impacts of bile exposure are mediated by TGR5 signaling pathways.胆汁暴露的多代影响是由 TGR5 信号通路介导的。
Sci Rep. 2018 Nov 15;8(1):16875. doi: 10.1038/s41598-018-34863-0.
8
Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.原发性胆汁性胆管炎和原发性硬化性胆管炎中的滤泡辅助性T细胞特征
Hepatol Commun. 2018 Sep 7;2(9):1051-1063. doi: 10.1002/hep4.1226. eCollection 2018 Sep.
9
Effect of aflatoxin B, benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells.黄曲霉毒素 B、苯并[a]芘和甲吡嗪对人肝 HepaRG 细胞转录组和表观遗传改变的影响。
Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
10
ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.ImmPort,旨在重新利用开放获取的免疫学检测数据,用于转化和临床研究。
Sci Data. 2018 Feb 27;5:180015. doi: 10.1038/sdata.2018.15.